AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15606516
Drug: Photodynamic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photodynamic therapy (PDT) with cumulative light dose of 20 J cm(‐2)
Trial: 11688021
Drug: Intra Mobiele
RxNorm normalized name: somatropin
DrugBank: Somatotropin (DB00052)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intra Mobiele Zylinder implants (IMZ group, n = 41)
Trial: 11688021
Drug: Brånemark implants
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Brånemark implants (Brå group, n = 17)
Trial: 11688021
Drug: Transmandibular Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transmandibular Implant (TMI group, n = 29)
Trial: 11688021
Drug: IMZ and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IMZ and Brånemark implants
Trial: 393027
Drug: Enterobiotic (antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enterobiotic (antibiotic prophylaxis)
Trial: 28295766
Drug: Veterinarian-administered otic
RxNorm normalized name: Absorbine Veterinary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Veterinarian-administered otic gel (Group A)
Trial: 28295766
Drug: Owner-administered treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Owner-administered treatment (Group B)
Trial: 25467586
Drug: AF-219, 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AF-219, 600 mg twice a day
Trial: 20615594
Drug: Hi-TENS combined
RxNorm normalized name: TEN
DrugBank: Pentaerythritol tetranitrate (DB06154)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hi-TENS combined with PCA-morphine
Trial: 20615594
Drug: PCA-morphine alone
RxNorm normalized name: lauryl PCA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCA-morphine alone
Trial: 11560127
Drug: ACTH-[1-24] (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACTH-[1-24] (250 mg in 500 mL normal saline, infused at a constant rate over 8 h)
Trial: 7843475
Drug: 12 plasma
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 plasma glucose and insulin determinations
Trial: 7843475
Drug: 26 plasma
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 26 plasma glucose and insulin determinations
Trial: 2662897
Drug: Interferon and
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon and descyclovir therapy
Trial: 31201041
Drug: High-Flow Nasal
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-Flow Nasal Oxygen (HFNO) at 50 L/min
Trial: 31201041
Drug: Standard Oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard Oxygen Therapy (SOT) via a standard facemask
Trial: 21266003
Drug: Lidocaine plus
RxNorm normalized name: Icy Hot Lidocaine Plus Menthol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine plus morphine sulfate
Trial: 19139846
Drug: Cruciate retaining
RxNorm normalized name: Gentiana cruciata root extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cruciate retaining implants
Trial: 9253908
Drug: Standard fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard fat emulsion dose (L)
Trial: 9253908
Drug: Withholding fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Withholding fat infusions (NL)
Trial: 8490316
Drug: Propofol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (2 mg/kg for induction)
Trial: 8490316
Drug: Thiopental (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopental (4 mg/kg for induction)
Trial: 8490316
Drug: Propofol (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (1 mg/kg after intubation)
Trial: 8490316
Drug: Thiopental (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopental (2 mg/kg after intubation)
Trial: 27185372
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg fulvestrant
Trial: 24091594
Drug: Intravenous ibandronate
RxNorm normalized name: ibandronate
DrugBank: Ibandronate (DB00710)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ibandronate (3 mg quarterly)
Trial: 24091594
Drug: Oral alendronate
RxNorm normalized name: alendronate
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral alendronate (70 mg weekly)
Trial: 24852042
Drug: Ustekinumab 45
RxNorm normalized name: USTEKINUMAB 45MG/0.5ML INJ 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ustekinumab 45 or 90 mg
Trial: 8879436
Drug: Oestradiol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oestradiol (2 mg/day) alone
Trial: 8879436
Drug: Oestradiol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oestradiol (2 mg/day) with norethisterone (1 mg/day)
Trial: 8879436
Drug: Oestradiol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oestradiol (2 mg/day) alone (sub-set of 32 patients)
Trial: 8879436
Drug: Oestradiol/norethisterone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oestradiol/norethisterone (1 mg/day)
Trial: 6723349
Drug: Controlled-release formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-release formulation of ketoprofen (2 capsules of 100 mg once daily)
Trial: 6723349
Drug: Conventional capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional capsule formulation of ketoprofen (100 mg capsules twice daily)
Trial: 30409490
Drug: Bevacizumab with
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bevacizumab with weekly paclitaxel
Trial: 30377220
Drug: Support for
RxNorm normalized name: GNP Diabetic Support Formula Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Support for free nicotine replacement therapy.
Trial: 17346807
Drug: Regular desloratadine
RxNorm normalized name: Desloratadine
DrugBank: Desloratadine (DB00967)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Regular desloratadine treatment
Trial: 17346807
Drug: On-demand desloratadine
RxNorm normalized name: Desloratadine
DrugBank: Desloratadine (DB00967)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: On-demand desloratadine treatment
Trial: 12972521
Drug: EC plus
RxNorm normalized name: Ivomec Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EC plus G-CSF (C group)
Trial: 12972521
Drug: EC plus
RxNorm normalized name: Ivomec Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EC plus LND plus G-CSF (D group)
Trial: 8674092
Drug: Propafenone 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propafenone 600 mg
Trial: 11789362
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (Control Group A)
Trial: 6628707
Drug: 1.0 mg
RxNorm normalized name: HYDROCORTISONE BUTYRATE 1.0 mg in 1 g TOPICAL CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg dl-norgestrel and 0.1 mg ethinylestradiol administered orally at 18 hours after LH rise and again at 30 hours
Trial: 24091849
Drug: Cisplatin +
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin + Paclitaxel (TP) 45 mg/m²/week
Trial: 24091849
Drug: Cisplatin +
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin + Docetaxel (DP) 20 mg/m²/week
Trial: 24091849
Drug: Cisplatin +
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin + Gemcitabine (GP) 350 mg/m²/week
Trial: 21840467
Drug: AquADEKs chewable
RxNorm normalized name: AquADEKs Chewable Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AquADEKs chewable tablets
Trial: 21840467
Drug: AquADEKs capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AquADEKs capsules
Trial: 21840467
Drug: Vitamins A
RxNorm normalized name: Vitamins A & D
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamins A (3 mg daily), E (200 mg daily), and D(3) (20 μg daily)
Trial: 15097304
Drug: Enrollment in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enrollment in the preventive HIV vaccine trial
Trial: 15097304
Drug: Concerns about
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concerns about vaccine-induced seropositivity
Trial: 8489107
Drug: Intravenous immunoglobulin
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immunoglobulin (IVIG) 500 mg/kg weekly
Trial: 3829912
Drug: Ranitidine HCl
RxNorm normalized name: ranitidine HCl
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine HCl 150 mg
Trial: 3829912
Drug: Cimetidine HCl
RxNorm normalized name: cimetidine HCl
DrugBank: Cimetidine (DB00501)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cimetidine HCl 400 mg
Trial: 1572123
Drug: Oral tetrahydroaminoacridine
RxNorm normalized name: Tetrahydroaminoacridine
DrugBank: Tacrine (DB00382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral tetrahydroaminoacridine (THA) and lecithin (75 to 200mg per day)
Trial: 2865021
Drug: Somatostatin intravenous
RxNorm normalized name: somatostatin
DrugBank: Somatostatin (DB09099)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Somatostatin intravenous infusion
Trial: 30449234
Drug: AR101 (peanut-derived
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AR101 (peanut-derived investigational biologic oral immunotherapy)
Trial: 28372591
Drug: Cooperation between
RxNorm normalized name: COOPER (AS CUPRIC OXIDE)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cooperation between geriatricians and general practitioners involving clinical geriatric assessment, medication review, and clinical follow-up over 24 weeks.
Trial: 26106623
Drug: Insulin sensitizing
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin sensitizing medications (thiazolidinediones and metformin)
Trial: 26106623
Drug: Insulin provision
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin provision strategy (insulin and/or sulfonylureas)
Trial: 20878571
Drug: FOLFOX chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FOLFOX chemotherapy (Group A, n=22)
Trial: 6316120
Drug: Levamisole as
RxNorm normalized name: Levamisole
DrugBank: Levamisole (DB00848)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levamisole as an adjunct to chemotherapy and radiotherapy
Trial: 6316120
Drug: Placebo as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo as an adjunct to chemotherapy and radiotherapy
Trial: 29660046
Drug: Optometrists providing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optometrists providing advice on smoking cessation medications
Trial: 27013060
Drug: Ticagrelor 90
RxNorm normalized name: ticagrelor 90 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticagrelor 90 mg bid (with or without 180 mg loading dose)
Trial: 27013060
Drug: Ticagrelor 90
RxNorm normalized name: ticagrelor 90 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticagrelor 90 mg bid (with loading dose)
Trial: 27013060
Drug: Ticagrelor 90
RxNorm normalized name: ticagrelor 90 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticagrelor 90 mg bid (without loading dose)
Trial: 27013060
Drug: Prasugrel 10
RxNorm normalized name: prasugrel 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel 10 mg QD
Trial: 19643320
Drug: Atorvastatin reload
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin reload (80 mg 12 h before intervention, with a further 40-mg pre-procedural dose)
Trial: 11313190
Drug: Electric toothbrush
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Electric toothbrush (Oral‐B‐7 EB 5 K, Braun AG, Kronberg, Germany)
Trial: 11313190
Drug: Manual toothbrush
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Manual toothbrush (Oral‐B, Power Tip, Braun AG, Kronberg, Germany)
Trial: 21246854
Drug: Auricular point
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Auricular point sticking (group A) - semen vaccariae fixed with plaster on various ear points, pressed 3 times daily for 5 mm each time, alternating sides every two days.
Trial: 21246854
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy of auricular point sticking and body acupuncture (group B) - same ear points as group A, plus body acupuncture at specific points (Zhongwan, Juanyuan, Tiansho, Zusanli, Sanyinjiao), applied once every two days.
Trial: 10214748
Drug: Rapid titration
RxNorm normalized name: Abreva Rapid Pain Relief
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rapid titration of pramipexole (full converted dose the day after stopping the former agonist)
Trial: 10214748
Drug: Slow titration
RxNorm normalized name: Slow Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow titration of pramipexole (up to 8 weeks to reach equivalent dosage)
Trial: 19352247
Drug: Particulate injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Particulate injections (5 bone marrow aspirates and cyst injections)
Trial: 19352247
Drug: Steroid injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid injections (2 injections)
Trial: 18381307
Drug: Bone marrow
RxNorm normalized name: bone marrow
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bone marrow injection
Trial: 15162891
Drug: SFGC 62.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SFGC 62.5 mg administered over 30 minutes
Trial: 15162891
Drug: SFGC 125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SFGC 125 mg administered over 60 minutes
Trial: 15162891
Drug: SFGC 62.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SFGC 62.5 mg administered over 4 minutes (second dose)
Trial: 15162891
Drug: SFGC 125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SFGC 125 mg administered over 7 minutes (second dose)
Trial: 9844330
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg at bedtime as maintenance therapy for one year
Trial: 405433
Drug: APPG (4.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: APPG (4.8 X 10(6) units of aqueous procaine penicillin G intramuscularly plus 1 g of probenecid orally)
Trial: 405433
Drug: TMP‐SMZ‐9 (nine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TMP‐SMZ‐9 (nine tablets of trimethoprim‐sulfamethoxazole; 720 mg of TMP and 3,600 mg of SMZ, orally as a single dose)
Trial: 405433
Drug: TMP‐SMZ‐12 (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TMP‐SMZ‐12 (12 tablets of TMP‐SMZ; 960 mg of TMP and 4,800 mg of SMZ, orally as two doses of six tablets taken at a 6‐hr interval)
Trial: 405433
Drug: Neisseria gonorrhoeae
RxNorm normalized name: Neisseria gonorrhoeae Ab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neisseria gonorrhoeae treatment failures
Trial: 27402427
Drug: Short (6-mm)
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short (6-mm) dental implants (TG)
Trial: 27402427
Drug: Sinus floor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sinus floor elevation (SFE) with longer (≥10-mm) implants (CG)
Trial: 25865751
Drug: 10 mg/ml
RxNorm normalized name: urea 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/ml of pectin
Trial: 25865751
Drug: 0, 3
RxNorm normalized name: Co-Q10, 30 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0, 3 and 10 mg/ml of pectin
Trial: 19621660
Drug: Cefazolin 1
RxNorm normalized name: cefazolin 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefazolin 1 g intravenously after induction of anesthesia
Trial: 16724543
Drug: Bronchobos capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bronchobos capsules (750 mg)
Trial: 16724543
Drug: Mucopront capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mucopront capsules (750 mg)
Trial: 9257324
Drug: Oral ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ketamine (60 mg administered six times/d)
Trial: 7687093
Drug: Midodrine (any
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midodrine (any dose)
Trial: 3829296
Drug: Oral ranitidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ranitidine 150 mg with 150 ml water
Trial: 3829296
Drug: Oral ranitidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ranitidine 150 mg with no further fluid
Trial: 3829296
Drug: Oral ranitidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ranitidine 150 mg (both groups)
Trial: 31126694
Drug: Contezolid 1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contezolid 1200 mg
Trial: 31126694
Drug: Contezolid 1600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contezolid 1600 mg
Trial: 31126694
Drug: Contezolid 800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contezolid 800 mg
Trial: 21779740
Drug: Electroacupuncture pulse
RxNorm normalized name: dulse extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroacupuncture pulse stimulation therapy alone
Trial: 21779740
Drug: Massage combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Massage combined with electroacupuncture pulse stimulation therapy
Trial: 24526184
Drug: Pramipexole (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pramipexole (0.5 mg)
Trial: 19220275
Drug: L-dopa (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-dopa (100 mg)
Trial: 9597557
Drug: Eprosartan 400
RxNorm normalized name: eprosartan 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eprosartan 400 mg
Trial: 9597557
Drug: Eprosartan 800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eprosartan 800 mg
Trial: 2893037
Drug: Non-invasive strategy
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-invasive strategy with thrombolysis (rTPA), heparin, and acetylsalicylic acid without immediate angiography and PTCA
Trial: 31169023
Drug: Intravitreal ranibizumab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal ranibizumab treatment for choroidal neovascularization due to pathologic myopia
Trial: 24077657
Drug: Intensive psychotherapy
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive psychotherapy (family‐focused therapy, interpersonal and social rhythm therapy, or cognitive‐behavioral therapy)
Trial: 24077657
Drug: Collaborative care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Collaborative care (three‐session comparison treatment)
Trial: 24032193
Drug: Behavior training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavior training after acupuncture treatment
Trial: 20452733
Drug: Transdermal steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal steroid delivery via iontophoresis or phonophoresis
Trial: 20452733
Drug: Transdermal steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal steroid delivery via iontophoresis
Trial: 20452733
Drug: Transdermal steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal steroid delivery via phonophoresis
Trial: 7972572
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of 35% CO2/65% O2 gas mixture
Trial: 7972572
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of air (placebo condition)
Trial: 4907811
Drug: Propranolol (120-320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (120-320 mg daily)
Trial: 29797990
Drug: Anti-anxiety and
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-anxiety and anti-depression treatment (experimental group)
Trial: 29797990
Drug: No anti-anxiety
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No anti-anxiety and anti-depression treatment (control group)
Trial: 29797990
Drug: Anti-anxiety and
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-anxiety and anti-depression treatment (experimental group) for tinnitus
Trial: 29797990
Drug: No anti-anxiety
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No anti-anxiety and anti-depression treatment (control group) for tinnitus
Trial: 17303710
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (3-g intravenous infusion)
Trial: 9892907
Drug: Interferon-gamma treatment
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon-gamma treatment
Trial: 2697199
Drug: mazindol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mazindol (2 mg/d)
Trial: 4584640
Drug: Deglycyrrhizinated liquorice
RxNorm normalized name: Liquorice
DrugBank: Licorice (DB10675)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deglycyrrhizinated liquorice extract (760 mg three times daily)
Trial: 26443438
Drug: R25 Reciproc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R25 Reciproc preparation
Trial: 26443438
Drug: Conventional hand
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional hand filing preparation
Trial: 10429571
Drug: Interauricular low‐intensity
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interauricular low‐intensity infrared laser therapy (0.89 nm, 7.6 J/cm)
Trial: 10429571
Drug: Interauricular laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interauricular laser therapy